TAM
ABMD

Tyers Asset Management’s Abiomed Inc ABMD Stock Holding History

Tyers Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$393K Buy
2,208
+448
+25% +$96.8K 0.01% 539
2019
Q2 		$458K Buy
1,760
+96
+6% +$25.5K 0.02% 504
2019
Q1 		$475K Buy
1,664
+192
+13% +$63.8K 0.02% 483
2018
Q4 		$479K Sell
1,472
-128
-8% -$44.5K 0.02% 418
2018
Q3 		$720K Sell
1,600
-3,904
-71% -$1.54M 0.02% 371
2018
Q2 		$2.25M Buy
5,504
+688
+14% +$249K 0.08% 199
2018
Q1 		$1.4M Buy
4,816
+224
+5% +$56.8K 0.05% 240
2017
Q4 		$861K Buy
4,592
+1,552
+51% +$290K 0.03% 308
2017
Q3 		$512K Buy
3,040
+320
+12% +$48.4K 0.02% 402
2017
Q2 		$390K Buy
2,720
+1,120
+70% +$151K 0.01% 474
2017
Q1 		$200K Sell
1,600
-352
-18% -$40.8K 0.01% 540
2016
Q4 		$220K Buy
+1,952
New +$226K 0.01% 486

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Tyers Asset Management's ABMD Position: Q3 2019 in Review

Tyers Asset Management increased its Abiomed Inc (ABMD) stake by 25% in Q3 2019, buying an estimated $96.8K and bringing the position to 2,208 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #539.

Tyers Asset Management first reported a position in ABMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $2.25M in Q2 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Tyers Asset Management held 2,208 shares of Abiomed Inc worth $393K as of Q3 2019.
  • Tyers Asset Management bought 448 Abiomed Inc shares in Q3 2019, an estimated $96.8K.
  • Abiomed Inc made up 0.01% of Tyers Asset Management's portfolio in Q3 2019, its #539 holding.
  • Tyers Asset Management first reported a position in Abiomed Inc in Q4 2016 and has held it in 12 quarters since.
  • Tyers Asset Management's Abiomed Inc position peaked at $2.25M in Q2 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.